ATE128867T1 - Verwendung von 3-aryl-5-alkylthio-4h-1,2,4- triazolen zur behandlung von überreflexen infolge von rückenmarkstrauma. - Google Patents

Verwendung von 3-aryl-5-alkylthio-4h-1,2,4- triazolen zur behandlung von überreflexen infolge von rückenmarkstrauma.

Info

Publication number
ATE128867T1
ATE128867T1 AT91121811T AT91121811T ATE128867T1 AT E128867 T1 ATE128867 T1 AT E128867T1 AT 91121811 T AT91121811 T AT 91121811T AT 91121811 T AT91121811 T AT 91121811T AT E128867 T1 ATE128867 T1 AT E128867T1
Authority
AT
Austria
Prior art keywords
triazoles
alkylthio
aryl
treatment
superreflexes
Prior art date
Application number
AT91121811T
Other languages
English (en)
Inventor
John H Kehne
Francis P Miller
John M Kane
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/769,201 external-priority patent/US5158968A/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE128867T1 publication Critical patent/ATE128867T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
AT91121811T 1990-12-20 1991-12-19 Verwendung von 3-aryl-5-alkylthio-4h-1,2,4- triazolen zur behandlung von überreflexen infolge von rückenmarkstrauma. ATE128867T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63066690A 1990-12-20 1990-12-20
US07/769,201 US5158968A (en) 1987-01-27 1991-10-04 3-aryl-5-alkylthio-4H-1,2,4-traizoles for treatment of hyperreflexia due to spinal trauma

Publications (1)

Publication Number Publication Date
ATE128867T1 true ATE128867T1 (de) 1995-10-15

Family

ID=27091200

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91121811T ATE128867T1 (de) 1990-12-20 1991-12-19 Verwendung von 3-aryl-5-alkylthio-4h-1,2,4- triazolen zur behandlung von überreflexen infolge von rückenmarkstrauma.

Country Status (8)

Country Link
EP (1) EP0495226B1 (de)
JP (1) JP3048191B2 (de)
KR (1) KR100192647B1 (de)
AT (1) ATE128867T1 (de)
AU (1) AU644500B2 (de)
DE (1) DE69113773T2 (de)
DK (1) DK0495226T3 (de)
IE (1) IE68424B1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0705077T3 (da) * 1993-05-28 1999-01-25 Origin Medsystems Inc Trokar med tilbagetrækkelig spids og føler
DE4339412A1 (de) * 1993-11-18 1995-05-24 Bayer Ag Verfahren und neue Zwischenprodukte zur Herstellung von Triazolinonen
JPH09315972A (ja) * 1996-03-22 1997-12-09 Chugai Pharmaceut Co Ltd 脊髄損傷治療剤
AR022230A1 (es) * 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2593084B2 (ja) * 1986-12-19 1997-03-19 メレルダウファーマスーティカルズ インコーポレーテッド ５−アリールー３ｈ−１，２，４−トリアゾールー３−オン類の神経変性障害の処置への用途
US4900743A (en) * 1987-01-27 1990-02-13 Merrell Dow Pharmaceuticals Inc. 3-aryl-5-alkylthio-4H-1,2,4-triazoles

Also Published As

Publication number Publication date
IE914460A1 (en) 1992-07-01
EP0495226A2 (de) 1992-07-22
KR920011490A (ko) 1992-07-24
KR100192647B1 (ko) 1999-06-15
EP0495226A3 (en) 1992-09-16
DE69113773D1 (de) 1995-11-16
DE69113773T2 (de) 1996-04-25
DK0495226T3 (da) 1995-11-27
JP3048191B2 (ja) 2000-06-05
JPH04334373A (ja) 1992-11-20
AU644500B2 (en) 1993-12-09
IE68424B1 (en) 1996-06-12
AU8969291A (en) 1992-06-25
EP0495226B1 (de) 1995-10-11

Similar Documents

Publication Publication Date Title
ES2052871T3 (es) Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano.
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
ATE234615T1 (de) Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren
DK465488A (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
ATE231131T1 (de) Verbindungen mit wachtumshormon freisetzenden eigenschaften
ATE128867T1 (de) Verwendung von 3-aryl-5-alkylthio-4h-1,2,4- triazolen zur behandlung von überreflexen infolge von rückenmarkstrauma.
IT1240683B (it) Composizione farmaceutica contenente egf
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
ATE123942T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva.
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE59708511D1 (de) Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
DK0510913T3 (da) Farmaceutiske sammensætninger indeholdende calcitonin
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
ATE30032T1 (de) N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer.
DE69117566D1 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ATE150645T1 (de) Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen
ATE315583T1 (de) Analoge des thymosin alpha 1
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE69203098D1 (de) Verwendung eines Polypeptids mit humaner Interleukin-2 Aktivität zur Herstellung pharmazeutischer Zusammensetzungen zur Behandlung von Pneumothoraxen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee